These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38279934)
1. Association of cuproptosis-related signature with the prognosis of patients with head and neck squamous cell carcinoma. Li Y; Sun C; Gu F; Yue J; Huang X; Yuan B; Wang Y; Chen R J Biomol Struct Dyn; 2024 Jan; ():1-12. PubMed ID: 38279934 [TBL] [Abstract][Full Text] [Related]
2. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer. Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617 [TBL] [Abstract][Full Text] [Related]
3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
4. Cuproptosis-related gene subtypes predict prognosis in patients with head and neck squamous cell carcinoma. Wang C; Zhou Y J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):58. PubMed ID: 37697421 [TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma. Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226 [TBL] [Abstract][Full Text] [Related]
6. The Prognostic Role of Cuproptosis in Head and Neck Squamous Cell Carcinoma Patients: A Comprehensive Analysis. Ding Q; Chen X; Hong W; Wang L; Liu W; Cai S; Chen X; Lu J; Qiu S Dis Markers; 2022; 2022():9996946. PubMed ID: 36092958 [TBL] [Abstract][Full Text] [Related]
7. Prognostic prediction of head and neck squamous cell carcinoma: Construction of cuproptosis-related long non-coding RNA signature. Huang Q; You Q; Zhu N; Wu Z; Xiang Z; Wu K; Ren J; Gui Y J Clin Lab Anal; 2022 Nov; 36(11):e24723. PubMed ID: 36189780 [TBL] [Abstract][Full Text] [Related]
8. A cuproptosis and copper metabolism-related gene prognostic index for head and neck squamous cell carcinoma. Zhang S; Zhang L; Lu H; Yao Y; Liu X; Hou J Front Oncol; 2022; 12():955336. PubMed ID: 36072790 [TBL] [Abstract][Full Text] [Related]
9. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma. Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201 [TBL] [Abstract][Full Text] [Related]
10. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma. Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461 [TBL] [Abstract][Full Text] [Related]
11. Identification of cuproptosis-related subtypes and characterization of the tumor microenvironment landscape in head and neck squamous cell carcinoma. Huang J; Xu Z; Yuan Z; Cheng L; Zhou C; Shen Y J Clin Lab Anal; 2022 Sep; 36(9):e24638. PubMed ID: 36082469 [TBL] [Abstract][Full Text] [Related]
12. Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation. Zhou L; Cheng Q; Hu Y; Tan H; Li X; Wu S; Zhou T; Zhou J Front Oncol; 2022; 12():1030802. PubMed ID: 36620545 [TBL] [Abstract][Full Text] [Related]
13. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas. Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP Front Immunol; 2022; 13():933973. PubMed ID: 36045691 [TBL] [Abstract][Full Text] [Related]
14. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma. Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X Front Oncol; 2023; 13():1152681. PubMed ID: 37333810 [TBL] [Abstract][Full Text] [Related]
15. Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma. Peng X; Zhu J; Liu S; Luo C; Wu X; Liu Z; Li Y; Yuan R Front Immunol; 2022; 13():990790. PubMed ID: 36248822 [TBL] [Abstract][Full Text] [Related]
16. Cuproptosis-related LncRNA signatures as a prognostic model for head and neck squamous cell carcinoma. Sun Q; Qin X; Zhao J; Gao T; Xu Y; Chen G; Bai G; Guo Z; Liu J Apoptosis; 2023 Feb; 28(1-2):247-262. PubMed ID: 36344660 [TBL] [Abstract][Full Text] [Related]
17. A novel cuproptosis-related lncRNA prognostic signature for predicting treatment and immune environment of head and neck squamous cell carcinoma. Huan C; Gao J Math Biosci Eng; 2022 Aug; 19(12):12127-12145. PubMed ID: 36653989 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC. Qin H; Sheng W; Zhang G; Yang Q; Yao S; Yue Y; Zhang P; Zhu Y; Wang Q; Chen Y; Zeng H; Weng J; Yu F; Yang J Front Genet; 2023; 14():1094793. PubMed ID: 36891150 [No Abstract] [Full Text] [Related]
20. Construction and validation of a prognostic model based on stage-associated signature genes of head and neck squamous cell carcinoma: a bioinformatics study. Chen L; Zhang X; Lin J; Wen Y; Chen Y; Chen CB Ann Transl Med; 2022 Dec; 10(24):1316. PubMed ID: 36660709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]